Pacer Advisors Inc. Has $31.01 Million Stock Position in Dolby Laboratories $DLB

Pacer Advisors Inc. boosted its stake in shares of Dolby Laboratories (NYSE:DLBFree Report) by 8.0% during the first quarter, Holdings Channel reports. The fund owned 516,292 shares of the electronics maker’s stock after acquiring an additional 38,389 shares during the period. Pacer Advisors Inc.’s holdings in Dolby Laboratories were worth $31,008,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Boothbay Fund Management LLC raised its stake in shares of Dolby Laboratories by 4.1% in the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after acquiring an additional 157 shares during the last quarter. Covestor Ltd lifted its position in shares of Dolby Laboratories by 6.0% during the fourth quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock worth $198,000 after purchasing an additional 175 shares in the last quarter. Fifth Third Bancorp grew its stake in shares of Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after purchasing an additional 192 shares during the last quarter. State of Michigan Retirement System increased its holdings in shares of Dolby Laboratories by 1.4% in the first quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock valued at $883,000 after purchasing an additional 200 shares in the last quarter. Finally, Raymond James Financial Inc. increased its holdings in shares of Dolby Laboratories by 1.0% in the second quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock valued at $1,808,000 after purchasing an additional 235 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on DLB shares. Barrington Research reaffirmed an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Rosenblatt Securities reissued a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Friday. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.

View Our Latest Stock Report on DLB

Insider Buying and Selling

In related news, CFO Robert J. Park sold 4,895 shares of Dolby Laboratories stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total transaction of $277,448.60. Following the completion of the sale, the chief financial officer directly owned 81,490 shares of the company’s stock, valued at $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $54.90, for a total value of $164,700.00. Following the completion of the sale, the senior vice president owned 80,603 shares of the company’s stock, valued at $4,425,104.70. This represents a 3.59% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 35,104 shares of company stock worth $1,924,252. Company insiders own 37.93% of the company’s stock.

Dolby Laboratories Price Performance

Shares of NYSE:DLB opened at $59.70 on Tuesday. The stock has a market cap of $5.65 billion, a price-to-earnings ratio of 25.40 and a beta of 0.81. The company has a 50 day moving average of $52.39 and a 200-day moving average of $58.51. Dolby Laboratories has a one year low of $48.26 and a one year high of $75.66.

Dolby Laboratories (NYSE:DLBGet Free Report) last announced its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. During the same period in the prior year, the business posted $0.78 earnings per share. Dolby Laboratories’s revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. Equities research analysts anticipate that Dolby Laboratories will post 3.21 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.4%. Dolby Laboratories’s dividend payout ratio is 61.28%.

Dolby Laboratories declared that its board has initiated a stock buyback program on Thursday, July 30th that authorizes the company to buyback $350.00 million in shares. This buyback authorization authorizes the electronics maker to purchase up to 7% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s management believes its shares are undervalued.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

See Also

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.